Moreover, we evaluated the effect of specific types of mutations (missense changes vs. loss of function) in correlation with histological and clinical data and could observe that in the cases classified as “higher risk” according to the EACSGE classification, the presence of damaging missense variants in TP53 negatively affected cancer-specific survival,. Here, TP53 is linked to cancer.